APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Therapy (IV) Bottles

Compare research editions
View pricing & licenses

Selected research

Industry Research

Intravenous Therapy (IV) Bottles Industry Research Report 2026

4 July 2026135 pages

Choose your research edition.

Industry ResearchIntravenous Therapy (IV) Bottles Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Therapy (IV) Bottles Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Intravenous Therapy (IV) Bottles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Therapy (IV) Bottles Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Therapy (IV) Bottles Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Intravenous Therapy (IV) Bottles market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Intravenous Therapy (IV) Bottles is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Intravenous Therapy (IV) Bottles is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Intravenous Therapy (IV) Bottles is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Intravenous Therapy (IV) Bottles include Vioser SA, Technoflex S.A, Sippex, Polycine GmbH, Metrix Company, Medicopack A/S, Kraton Corporation, JW Life Science and JOTOP Glass, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Intravenous Therapy (IV) Bottles market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Intravenous Therapy (IV) Bottles Market by Company

Vioser SA

Technoflex S.A

Sippex

Polycine GmbH

Metrix Company

Medicopack A/S

Kraton Corporation

JW Life Science

JOTOP Glass

ICU Medical

Fresenius AG

Euro Healthcare Pvt. Ltd.

Baxter Healthcare Limited

Bausch Group

B. Braun

Intravenous Therapy (IV) Bottles Segment by Type

Plastic IV Bottles

Glass IV Bottle

Intravenous Therapy (IV) Bottles Segment by Application

Hospital

Clinic

Others

Intravenous Therapy (IV) Bottles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Therapy (IV) Bottles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Therapy (IV) Bottles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Therapy (IV) Bottles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Intravenous Therapy (IV) Bottles manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Intravenous Therapy (IV) Bottles by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Intravenous Therapy (IV) Bottles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Intravenous Therapy (IV) Bottles Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Intravenous Therapy (IV) Bottles Sales (k units) of Manufacturers (2021-2026) Table 7. Global Intravenous Therapy (IV) Bottles Sales Market Share by Manufacturers (2021-2026) Table 8. Global Intravenous Therapy (IV) Bottles Revenue of Manufacturers (2021-2026) Table 9. Global Intravenous Therapy (IV) Bottles Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Intravenous Therapy (IV) Bottles Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Intravenous Therapy (IV) Bottles Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Intravenous Therapy (IV) Bottles, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Intravenous Therapy (IV) Bottles, Product Type & Application Table 14. Global Intravenous Therapy (IV) Bottles Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Intravenous Therapy (IV) Bottles by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Vioser SA Company Information Table 19. Vioser SA Business Overview Table 20. Vioser SA Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio Table 22. Vioser SA Recent Developments Table 23. Technoflex S.A Company Information Table 24. Technoflex S.A Business Overview Table 25. Technoflex S.A Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio Table 27. Technoflex S.A Recent Developments Table 28. Sippex Company Information Table 29. Sippex Business Overview Table 30. Sippex Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Sippex Intravenous Therapy (IV) Bottles Product Portfolio Table 32. Sippex Recent Developments Table 33. Polycine GmbH Company Information Table 34. Polycine GmbH Business Overview Table 35. Polycine GmbH Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio Table 37. Polycine GmbH Recent Developments Table 38. Metrix Company Company Information Table 39. Metrix Company Business Overview Table 40. Metrix Company Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio Table 42. Metrix Company Recent Developments Table 43. Medicopack A/S Company Information Table 44. Medicopack A/S Business Overview Table 45. Medicopack A/S Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio Table 47. Medicopack A/S Recent Developments Table 48. Kraton Corporation Company Information Table 49. Kraton Corporation Business Overview Table 50. Kraton Corporation Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio Table 52. Kraton Corporation Recent Developments Table 53. JW Life Science Company Information Table 54. JW Life Science Business Overview Table 55. JW Life Science Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio Table 57. JW Life Science Recent Developments Table 58. JOTOP Glass Company Information Table 59. JOTOP Glass Business Overview Table 60. JOTOP Glass Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio Table 62. JOTOP Glass Recent Developments Table 63. ICU Medical Company Information Table 64. ICU Medical Business Overview Table 65. ICU Medical Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio Table 67. ICU Medical Recent Developments Table 68. Fresenius AG Company Information Table 69. Fresenius AG Business Overview Table 70. Fresenius AG Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio Table 72. Fresenius AG Recent Developments Table 73. Euro Healthcare Pvt. Ltd. Company Information Table 74. Euro Healthcare Pvt. Ltd. Business Overview Table 75. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio Table 77. Euro Healthcare Pvt. Ltd. Recent Developments Table 78. Baxter Healthcare Limited Company Information Table 79. Baxter Healthcare Limited Business Overview Table 80. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio Table 82. Baxter Healthcare Limited Recent Developments Table 83. Bausch Group Company Information Table 84. Bausch Group Business Overview Table 85. Bausch Group Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio Table 87. Bausch Group Recent Developments Table 88. B. Braun Company Information Table 89. B. Braun Business Overview Table 90. B. Braun Intravenous Therapy (IV) Bottles Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. B. Braun Intravenous Therapy (IV) Bottles Product Portfolio Table 92. B. Braun Recent Developments Table 93. Global Intravenous Therapy (IV) Bottles Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Intravenous Therapy (IV) Bottles Sales by Region (2021-2026) & (k units) Table 95. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2021-2026) Table 96. Global Intravenous Therapy (IV) Bottles Sales by Region (2027-2032) & (k units) Table 97. Global Intravenous Therapy (IV) Bottles Sales Market Share by Region (2027-2032) Table 98. Global Intravenous Therapy (IV) Bottles Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2021-2026) Table 100. Global Intravenous Therapy (IV) Bottles Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Region (2027-2032) Table 102. North America Intravenous Therapy (IV) Bottles Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 104. North America Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 105. North America Intravenous Therapy (IV) Bottles Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Intravenous Therapy (IV) Bottles Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Intravenous Therapy (IV) Bottles Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 109. Europe Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 110. Europe Intravenous Therapy (IV) Bottles Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Intravenous Therapy (IV) Bottles Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Intravenous Therapy (IV) Bottles Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 119. South America Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 120. South America Intravenous Therapy (IV) Bottles Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Intravenous Therapy (IV) Bottles Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2026) & (k units) Table 128. Global Intravenous Therapy (IV) Bottles Sales by Type (2027-2032) & (k units) Table 129. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2026) Table 130. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2027-2032) Table 131. Global Intravenous Therapy (IV) Bottles Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Intravenous Therapy (IV) Bottles Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2026) Table 134. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2027-2032) Table 135. Global Intravenous Therapy (IV) Bottles Price by Type (2021-2026) & (USD/unit) Table 136. Global Intravenous Therapy (IV) Bottles Price by Type (2027-2032) & (USD/unit) Table 137. Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2026) & (k units) Table 138. Global Intravenous Therapy (IV) Bottles Sales by Application (2027-2032) & (k units) Table 139. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2026) Table 140. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2027-2032) Table 141. Global Intravenous Therapy (IV) Bottles Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Intravenous Therapy (IV) Bottles Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2026) Table 144. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2027-2032) Table 145. Global Intravenous Therapy (IV) Bottles Price by Application (2021-2026) & (USD/unit) Table 146. Global Intravenous Therapy (IV) Bottles Price by Application (2027-2032) & (USD/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Intravenous Therapy (IV) Bottles Distributors List Table 150. Intravenous Therapy (IV) Bottles Customers List Table 151. Intravenous Therapy (IV) Bottles Industry Trends Table 152. Intravenous Therapy (IV) Bottles Industry Drivers Table 153. Intravenous Therapy (IV) Bottles Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Intravenous Therapy (IV) Bottles Product Image Figure 5. Global Intravenous Therapy (IV) Bottles Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Intravenous Therapy (IV) Bottles Market Size (2021-2032) & (US$ Million) Figure 7. Global Intravenous Therapy (IV) Bottles Sales (2021-2032) & (k units) Figure 8. Global Intravenous Therapy (IV) Bottles Average Price (USD/unit) & (2021-2032) Figure 9. Plastic IV Bottles Product Image Figure 10. Glass IV Bottle Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Others Product Image Figure 14. Global Intravenous Therapy (IV) Bottles Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Intravenous Therapy (IV) Bottles, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Intravenous Therapy (IV) Bottles Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Intravenous Therapy (IV) Bottles Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Intravenous Therapy (IV) Bottles Sales by Region in 2025 Figure 20. Global Intravenous Therapy (IV) Bottles Revenue by Region in 2025 Figure 21. North America Intravenous Therapy (IV) Bottles Market Size by Country in 2025 Figure 22. North America Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 23. North America Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2021-2032) Figure 24. United States Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Intravenous Therapy (IV) Bottles Market Size by Country in 2025 Figure 28. Europe Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 29. Europe Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2021-2032) Figure 30. Germany Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Intravenous Therapy (IV) Bottles Market Size by Country in 2025 Figure 41. Asia Pacific Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2021-2032) Figure 43. China Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Intravenous Therapy (IV) Bottles Market Size by Country in 2025 Figure 52. South America Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 53. South America Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2021-2032) Figure 54. Brazil Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Intravenous Therapy (IV) Bottles Market Size by Country in 2025 Figure 58. Middle East and Africa Intravenous Therapy (IV) Bottles Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Intravenous Therapy (IV) Bottles Revenue Market Share by Country (2021-2032) Figure 60. Egypt Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Intravenous Therapy (IV) Bottles Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2032) Figure 66. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2032) Figure 67. Global Intravenous Therapy (IV) Bottles Price (USD/unit) by Type (2021-2032) Figure 68. Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2032) Figure 69. Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2032) Figure 70. Global Intravenous Therapy (IV) Bottles Price (USD/unit) by Application (2021-2032) Figure 71. Intravenous Therapy (IV) Bottles Value Chain Figure 72. Intravenous Therapy (IV) Bottles Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges

Scope & coverage.

Types
  • Plastic IV Bottles
  • Glass IV Bottle
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Vioser SA
  • Technoflex S.A
  • Sippex
  • Polycine GmbH
  • Metrix Company
  • Medicopack A/S
  • Kraton Corporation
  • JW Life Science
  • JOTOP Glass
  • ICU Medical
  • Fresenius AG
  • Euro Healthcare Pvt. Ltd.
  • Baxter Healthcare Limited
  • Bausch Group
  • B. Braun

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Intravenous Therapy (IV) Bottles Market Size (2021-2032)
  4. 2.2.2 Global Intravenous Therapy (IV) Bottles Sales (2021-2032)
  5. 2.2.3 Global Intravenous Therapy (IV) Bottles Market Average Price (2021-2032)
  6. 2.3 Intravenous Therapy (IV) Bottles by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Plastic IV Bottles
  9. 2.3.3 Glass IV Bottle
  10. 2.4 Intravenous Therapy (IV) Bottles by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Intravenous Therapy (IV) Bottles Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Intravenous Therapy (IV) Bottles Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Intravenous Therapy (IV) Bottles Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Intravenous Therapy (IV) Bottles Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Intravenous Therapy (IV) Bottles Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Intravenous Therapy (IV) Bottles, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Intravenous Therapy (IV) Bottles, Product Type & Application
  8. 3.8 Global Manufacturers of Intravenous Therapy (IV) Bottles, Established Date
  9. 3.9 Global Intravenous Therapy (IV) Bottles Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Vioser SA
  2. 4.1.1 Vioser SA Company Information
  3. 4.1.2 Vioser SA Business Overview
  4. 4.1.3 Vioser SA Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Vioser SA Intravenous Therapy (IV) Bottles Product Portfolio
  6. 4.1.5 Vioser SA Recent Developments
  7. 4.2 Technoflex S.A
  8. 4.2.1 Technoflex S.A Company Information
  9. 4.2.2 Technoflex S.A Business Overview
  10. 4.2.3 Technoflex S.A Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Technoflex S.A Intravenous Therapy (IV) Bottles Product Portfolio
  12. 4.2.5 Technoflex S.A Recent Developments
  13. 4.3 Sippex
  14. 4.3.1 Sippex Company Information
  15. 4.3.2 Sippex Business Overview
  16. 4.3.3 Sippex Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sippex Intravenous Therapy (IV) Bottles Product Portfolio
  18. 4.3.5 Sippex Recent Developments
  19. 4.4 Polycine GmbH
  20. 4.4.1 Polycine GmbH Company Information
  21. 4.4.2 Polycine GmbH Business Overview
  22. 4.4.3 Polycine GmbH Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Polycine GmbH Intravenous Therapy (IV) Bottles Product Portfolio
  24. 4.4.5 Polycine GmbH Recent Developments
  25. 4.5 Metrix Company
  26. 4.5.1 Metrix Company Company Information
  27. 4.5.2 Metrix Company Business Overview
  28. 4.5.3 Metrix Company Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Metrix Company Intravenous Therapy (IV) Bottles Product Portfolio
  30. 4.5.5 Metrix Company Recent Developments
  31. 4.6 Medicopack A/S
  32. 4.6.1 Medicopack A/S Company Information
  33. 4.6.2 Medicopack A/S Business Overview
  34. 4.6.3 Medicopack A/S Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Medicopack A/S Intravenous Therapy (IV) Bottles Product Portfolio
  36. 4.6.5 Medicopack A/S Recent Developments
  37. 4.7 Kraton Corporation
  38. 4.7.1 Kraton Corporation Company Information
  39. 4.7.2 Kraton Corporation Business Overview
  40. 4.7.3 Kraton Corporation Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kraton Corporation Intravenous Therapy (IV) Bottles Product Portfolio
  42. 4.7.5 Kraton Corporation Recent Developments
  43. 4.8 JW Life Science
  44. 4.8.1 JW Life Science Company Information
  45. 4.8.2 JW Life Science Business Overview
  46. 4.8.3 JW Life Science Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 JW Life Science Intravenous Therapy (IV) Bottles Product Portfolio
  48. 4.8.5 JW Life Science Recent Developments
  49. 4.9 JOTOP Glass
  50. 4.9.1 JOTOP Glass Company Information
  51. 4.9.2 JOTOP Glass Business Overview
  52. 4.9.3 JOTOP Glass Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 JOTOP Glass Intravenous Therapy (IV) Bottles Product Portfolio
  54. 4.9.5 JOTOP Glass Recent Developments
  55. 4.10 ICU Medical
  56. 4.10.1 ICU Medical Company Information
  57. 4.10.2 ICU Medical Business Overview
  58. 4.10.3 ICU Medical Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 ICU Medical Intravenous Therapy (IV) Bottles Product Portfolio
  60. 4.10.5 ICU Medical Recent Developments
  61. 4.11 Fresenius AG
  62. 4.11.1 Fresenius AG Company Information
  63. 4.11.2 Fresenius AG Business Overview
  64. 4.11.3 Fresenius AG Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Fresenius AG Intravenous Therapy (IV) Bottles Product Portfolio
  66. 4.11.5 Fresenius AG Recent Developments
  67. 4.12 Euro Healthcare Pvt. Ltd.
  68. 4.12.1 Euro Healthcare Pvt. Ltd. Company Information
  69. 4.12.2 Euro Healthcare Pvt. Ltd. Business Overview
  70. 4.12.3 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Euro Healthcare Pvt. Ltd. Intravenous Therapy (IV) Bottles Product Portfolio
  72. 4.12.5 Euro Healthcare Pvt. Ltd. Recent Developments
  73. 4.13 Baxter Healthcare Limited
  74. 4.13.1 Baxter Healthcare Limited Company Information
  75. 4.13.2 Baxter Healthcare Limited Business Overview
  76. 4.13.3 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Baxter Healthcare Limited Intravenous Therapy (IV) Bottles Product Portfolio
  78. 4.13.5 Baxter Healthcare Limited Recent Developments
  79. 4.14 Bausch Group
  80. 4.14.1 Bausch Group Company Information
  81. 4.14.2 Bausch Group Business Overview
  82. 4.14.3 Bausch Group Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bausch Group Intravenous Therapy (IV) Bottles Product Portfolio
  84. 4.14.5 Bausch Group Recent Developments
  85. 4.15 B. Braun
  86. 4.15.1 B. Braun Company Information
  87. 4.15.2 B. Braun Business Overview
  88. 4.15.3 B. Braun Intravenous Therapy (IV) Bottles Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 B. Braun Intravenous Therapy (IV) Bottles Product Portfolio
  90. 4.15.5 B. Braun Recent Developments
5 Global Intravenous Therapy (IV) Bottles Market Scenario by Region
  1. 5.1 Global Intravenous Therapy (IV) Bottles Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Intravenous Therapy (IV) Bottles Sales by Region: 2021-2032
  3. 5.2.1 Global Intravenous Therapy (IV) Bottles Sales by Region: 2021-2026
  4. 5.2.2 Global Intravenous Therapy (IV) Bottles Sales by Region: 2027-2032
  5. 5.3 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2021-2032
  6. 5.3.1 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2021-2026
  7. 5.3.2 Global Intravenous Therapy (IV) Bottles Revenue by Region: 2027-2032
  8. 5.4 North America Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
  9. 5.4.1 North America Intravenous Therapy (IV) Bottles Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  11. 5.4.3 North America Intravenous Therapy (IV) Bottles Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
  16. 5.5.1 Europe Intravenous Therapy (IV) Bottles Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  18. 5.5.3 Europe Intravenous Therapy (IV) Bottles Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Intravenous Therapy (IV) Bottles Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Intravenous Therapy (IV) Bottles Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
  41. 5.7.1 South America Intravenous Therapy (IV) Bottles Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  43. 5.7.3 South America Intravenous Therapy (IV) Bottles Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Intravenous Therapy (IV) Bottles Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Intravenous Therapy (IV) Bottles Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Intravenous Therapy (IV) Bottles Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Intravenous Therapy (IV) Bottles Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2032)
  2. 6.1.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Intravenous Therapy (IV) Bottles Sales Market Share by Type (2021-2032)
  4. 6.2 Global Intravenous Therapy (IV) Bottles Revenue by Type (2021-2032)
  5. 6.2.1 Global Intravenous Therapy (IV) Bottles Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Intravenous Therapy (IV) Bottles Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2032)
  2. 7.1.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Intravenous Therapy (IV) Bottles Sales Market Share by Application (2021-2032)
  4. 7.2 Global Intravenous Therapy (IV) Bottles Revenue by Application (2021-2032)
  5. 7.2.1 Global Intravenous Therapy (IV) Bottles Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Intravenous Therapy (IV) Bottles Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Intravenous Therapy (IV) Bottles Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Intravenous Therapy (IV) Bottles Value Chain Analysis
  2. 8.1.1 Intravenous Therapy (IV) Bottles Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Intravenous Therapy (IV) Bottles Production Mode & Process
  5. 8.2 Intravenous Therapy (IV) Bottles Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Intravenous Therapy (IV) Bottles Distributors
  8. 8.2.3 Intravenous Therapy (IV) Bottles Customers
9 Global Intravenous Therapy (IV) Bottles Analyzing Market Dynamics
  1. 9.1 Intravenous Therapy (IV) Bottles Industry Trends
  2. 9.2 Intravenous Therapy (IV) Bottles Industry Drivers
  3. 9.3 Intravenous Therapy (IV) Bottles Industry Opportunities and Challenges
  4. 9.4 Intravenous Therapy (IV) Bottles Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst